🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase I double-blind, randomized, placebo-controlled study in 50 ...
Status
Completed
Location
Saint Louis University - Center for Vaccine Development
Start Date
2018-08-15
Trial ID
NCT03553940
The primary objective of the study was to investigate the safety and tolera...
Status
Completed
Location
Multiple Locations
Start Date
2002-08
Trial ID
NCT00224783
The primary objective of this study is to demonstrate the immunologic nonin...
Status
Completed
Location
Research Site
Start Date
2010-03
Trial ID
NCT01091246
Treatments Being Tested
Over the past decade, avian influenza (AI) has become a major health concer...
Status
Completed
Location
Center for Immunization Research Inpatient Unit, Mason F. Lord Building, 4940 Eastern Avenue
Start Date
2007-09
Trial ID
NCT00516035
The primary objective of this study was to perform a variety of assays on b...
Status
Completed
Location
David M. Radin, MD
Start Date
2001-09
Trial ID
NCT00192309
The purpose of this study is to evaluate safety and reactogenicity of live ...
Status
Completed
Location
Faculty of Tropical Medicine
Start Date
2012-05
Trial ID
NCT01656356
Treatments Being Tested
The goal of this intervention study is to learn if giving children influenz...
Status
Recruiting
Location
University of Turku
Start Date
2025-10-27
Trial ID
NCT07310472
Treatments Being Tested
To evaluate the bacterial-viral interactions between LPS and Fluenz as a mo...
Status
Completed
Location
Multiple Locations
Start Date
2015-12
Trial ID
NCT02642237
This study is a Phase 1, 2-part, randomised, double-blind, controlled, clin...
Status
Completed
Location
Lis Gilmour, Senior Project Manager
Start Date
2022-04-11
Trial ID
NCT05223179
Treatments Being Tested
This is one project of a larger ongoing study related to the immune system'...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2019-10-08
Trial ID
NCT03898986
Treatments Being Tested